A first-of-its-kind law in Tennessee will limit the language lawyers can use in ads seeking to sue drug makers; consumers spend significantly more on healthcare in the week after they get their tax return; New Hampshire has seen 79 new cases of hepatitis A since November.
Tennessee has adopted a first-of-its-kind law that, starting July, will limit the language lawyers can use in ads soliciting patients who may have been harmed by a drug or medical device. According to STAT News, the law will not prohibit the running of ads as a whole, but it will place certain restrictions on the ads, including banning use of language suggesting that they are medical warnings or not disclosing that the ad was paid for by a lawyer, as well as not allowing the display of logos of government agencies like the FDA. The law will also require that ads tell consumers to consult with their doctor before stopping the medication.Consumers increase their total out-of-pocket healthcare spending by 60% in the week after receiving their tax return, according to an analysis from JP Morgan Chase, which analyzed 1.2 million checking account holders who received a tax refund between 2014 and 2016. Spending remained higher in the 75 days following tax returns, during which consumers spent 20% more than they did before the refund. Consumers were more likely to visit their dentists’ and doctors’ offices, as well as pay outstanding hospital bills.Since November, New Hampshire has seen 79 new cases of hepatitis A, a significant spike in the typical 6-7 cases seen per year. In March alone, there were 33 new cases, causing state officials to urge people in the state to get vaccinated, reported New Hampshire Union Leader. Beth Daly, chief of the state’s Bureau of Infectious Disease Control has attributed the outbreak to people in the state using recreational drugs, as well as homeless individuals. Since the outbreak, 1 person has died as a result of the infection.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen